Search

everythinglearnresearchcommunity

for

Search:↓

A thorough diagnostic process and teamwork are crucial for managing complex hyperandrogenism in postmenopausal women.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

Some conditions mimic PCOS symptoms and need careful diagnosis to treat potentially serious health issues.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Pregnancy can cause various skin changes and diseases, with PUPPP being the most common skin condition specific to pregnancy.

Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

Hormones like testosterone and estrogen significantly affect hair growth and structure.

Most skin changes during pregnancy go away after giving birth.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

A woman's male-like symptoms and high testosterone were due to ovarian hilus-cell hyperplasia, which improved after surgery.

The conclusion is that lifestyle changes and weight loss are first-line treatments for infertility due to anovulation, with various medications and assisted reproductive technologies as additional options.

Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.

Sertoliform endometrioid carcinoma of the ovary, though rare, has a good prognosis when treated early.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Pregnancy can cause skin pigmentation, stretch marks, and changes in hair, nails, and sweat glands, with most resolving after birth.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.